2219 Stock Overview
Owns and operates a network of ophthalmic hospitals and optical centers in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Chaoju Eye Care Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$3.09 |
| 52 Week High | HK$4.27 |
| 52 Week Low | HK$2.58 |
| Beta | 0.48 |
| 1 Month Change | 15.73% |
| 3 Month Change | 4.75% |
| 1 Year Change | -16.94% |
| 3 Year Change | -37.20% |
| 5 Year Change | n/a |
| Change since IPO | -78.09% |
Recent News & Updates
Returns At Chaoju Eye Care Holdings (HKG:2219) Appear To Be Weighed Down
Jan 23
Return Trends At Chaoju Eye Care Holdings (HKG:2219) Aren't Appealing
Sep 26Recent updates
Returns At Chaoju Eye Care Holdings (HKG:2219) Appear To Be Weighed Down
Jan 23Return Trends At Chaoju Eye Care Holdings (HKG:2219) Aren't Appealing
Sep 26Chaoju Eye Care Holdings' (HKG:2219) Upcoming Dividend Will Be Larger Than Last Year's
Jun 09Chaoju Eye Care Holdings (HKG:2219) Will Pay A Larger Dividend Than Last Year At CN¥0.2975
Apr 24Chaoju Eye Care Holdings' (HKG:2219) Solid Earnings Have Been Accounted For Conservatively
Apr 02Chaoju Eye Care Holdings (HKG:2219) Is Paying Out A Larger Dividend Than Last Year
Apr 01An Intrinsic Calculation For Chaoju Eye Care Holdings Limited (HKG:2219) Suggests It's 20% Undervalued
Jul 10Chaoju Eye Care Holdings (HKG:2219) Is Paying Out A Larger Dividend Than Last Year
Jun 07Earnings Report: Chaoju Eye Care Holdings Limited Missed Revenue Estimates By 7.9%
Mar 31A Look At The Fair Value Of Chaoju Eye Care Holdings Limited (HKG:2219)
Feb 28Chaoju Eye Care Holdings (HKG:2219) Could Be Struggling To Allocate Capital
Feb 06Chaoju Eye Care Holdings (HKG:2219) Is Reinvesting At Lower Rates Of Return
Aug 31We Think Chaoju Eye Care Holdings' (HKG:2219) Solid Earnings Are Understated
Apr 04Shareholder Returns
| 2219 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 2.3% | -0.6% | 0.9% |
| 1Y | -16.9% | -18.2% | 22.3% |
Return vs Industry: 2219 exceeded the Hong Kong Healthcare industry which returned -18.2% over the past year.
Return vs Market: 2219 underperformed the Hong Kong Market which returned 22.3% over the past year.
Price Volatility
| 2219 volatility | |
|---|---|
| 2219 Average Weekly Movement | 3.4% |
| Healthcare Industry Average Movement | 6.8% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in HK Market | 13.8% |
| 10% least volatile stocks in HK Market | 3.1% |
Stable Share Price: 2219 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2219's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 2,648 | Bozhou Zhang | www.chaojueye.com |
Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, myopia prevention and control, dry eye syndrome, and oculoplastic, as well as optical products and services. The company also provides basic ophthalmic services, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, and pediatric eye diseases.
Chaoju Eye Care Holdings Limited Fundamentals Summary
| 2219 fundamental statistics | |
|---|---|
| Market cap | HK$2.13b |
| Earnings (TTM) | HK$229.40m |
| Revenue (TTM) | HK$1.51b |
9.3x
P/E Ratio1.4x
P/S RatioIs 2219 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2219 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.41b |
| Cost of Revenue | CN¥776.92m |
| Gross Profit | CN¥634.19m |
| Other Expenses | CN¥419.43m |
| Earnings | CN¥214.75m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.31 |
| Gross Margin | 44.94% |
| Net Profit Margin | 15.22% |
| Debt/Equity Ratio | 0.3% |
How did 2219 perform over the long term?
See historical performance and comparisonDividends
8.1%
Current Dividend Yield103%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 01:25 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Chaoju Eye Care Holdings Limited is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yichi Zhang | China International Capital Corporation Limited |
| null null | Guoyuan Securities (HK) Ltd |
| Wen Dai | Huatai Research |